Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05492825 · ClinicalTrials.gov registry record · NA

IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

A NA study of Chronic Pain and Opioid Use Disorder, sponsored by Albert Einstein College of Medicine.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT05492825: Recruiting NA study of Chronic Pain and Opioid Use Disorder, sponsored by Albert Einstein College of Medicine.

NCT05492825 is a NA study of Chronic Pain and Opioid Use Disorder that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 180 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05492825, a NA study of Chronic Pain and Opioid Use Disorder, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This is a pragmatic, open label, randomized controlled trial with 1:1:1 allocation to 12 weeks of: (1) onsite yoga at opioid treatment programs (OTPs), (2) onsite physical therapy (PT) at OTPs, or (3) treatment as usual (TAU). Participants will be 180 individuals with chronic back pain receiving treatment for opioid use disorder (OUD) in community-based OTPs. Through research visits at screening, baseline, and months 1, 2, 3, 6, and 9, the investigators will evaluate pain and opioid use outcomes and implementation outcomes.

Primary Outcome

Change in Pain Intensity on average over the prior 7-day period will be assessed using the Brief Pain Inventory (BPI) pain intensity subscale. The BPI pain intensity subscale consists of 4 items which asks patients to rate their worst pain, least pain, average pain, and current pain using a 0-10 numeric rating scale (NRS), where 0 represents "No pain" and 10 represents "Pain as bad as you can imagine" such that higher scores are associated with greater pain intensity. Scores from the four items

Interventions

  • OTHER Physical Therapy
  • OTHER Yoga
  • OTHER Treatment As Usual

Study Locations (1)

New York

  • Montefiore DoSA Wellness Centers - The Bronx

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-02-27
Est. Completion 2026-11-02
Phase NA
Albert Einstein College of Medicine

175 total trials

What NCT05492825 shows while recruiting

NCT05492825 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (77% lower).

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Physical Therapy is the first listed.

NCT05492825 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05492825 about?

NCT05492825 is a clinical study titled "IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs". This is a pragmatic, open label, randomized controlled trial with 1:1:1 allocation to 12 weeks of: (1) onsite yoga at opioid treatment programs (OTPs), (2) onsite physical therapy (PT) at OTPs, or (3) treatment as usual (TAU). Participants will be 180 individuals with chronic back pain receiving tre...

What is the current status of trial NCT05492825?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-02-27. Estimated completion is 2026-11-02.

What conditions does trial NCT05492825 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder, Substance Use Disorders, Back Pain Lower Back Chronic.

What interventions are being tested in trial NCT05492825?

The interventions under investigation include: Physical Therapy (OTHER), Yoga (OTHER), Treatment As Usual (OTHER).

Who is sponsoring clinical trial NCT05492825?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05492825 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05492825's enrollment target sits among peer trials

180 92nd of 301 higher than 209 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05492825, the US trial registry maintained by the National Library of Medicine. NCT05492825 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.